Literature DB >> 11407191

Communication Capacity Scale and Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: a validation study.

T Morita1, J Tsunoda, S Inoue, S Chihara, K Oka.   

Abstract

Although valid measurement of the severity of terminal delirium is of great importance in palliative care settings, existing instruments have considerable limitations. In order to quantify patients' communication capacity and agitated behaviour, two new operational observer-rating scales, the Communication Capacity Scale (Communication Scale) and Agitation Distress Scale (Agitation Scale), were validated. Thirty terminally ill cancer patients diagnosed with delirium were evaluated simultaneously by two palliative care physicians blinded to each other's coding using the Communication Scale and Agitation Scale. In addition, the Memorial Delirium Assessment Scale (MDAS), Delirium Rating Scale (DRS) and Sedation Scale were rated by one researcher. Both scales achieved high internal consistency and inter-rater reliability with Cronbach's alpha coefficients of 0.91 and 0.96, and Cohen's kappa values on each item of 0.72-1.00. The principal components analysis resulted in the emergence of only one component for each scale. The total score on the Communication Scale was highly associated with that of the MDAS (rho = 0.78), Sedation Scale (rho = 0.86), and cognitive items from the MDAS and DRS (rho = 0.83). The whole score on the Agitation Scale was significantly correlated with that of the DRS (rho = 0.61) and agitation items from the MDAS and DRS (rho = 0.61). In conclusion, the Communication Scale and Agitation Scale have acceptable reliability and validity to quantify patients' communication capacity and agitation symptoms of terminally ill cancer patients with delirium.

Entities:  

Mesh:

Year:  2001        PMID: 11407191     DOI: 10.1191/026921601678576185

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  15 in total

1.  New Delirium Severity Indicators: Generation and Internal Validation in the Better Assessment of Illness (BASIL) Study.

Authors:  Sarinnapha M Vasunilashorn; Dena Schulman-Green; Douglas Tommet; Tamara G Fong; Tammy T Hshieh; Edward R Marcantonio; Eran D Metzger; Eva M Schmitt; Patricia A Tabloski; Thomas G Travison; Yun Gou; Benjamin Helfand; Sharon K Inouye; Richard N Jones
Journal:  Dement Geriatr Cogn Disord       Date:  2020-06-17       Impact factor: 2.959

Review 2.  Delirium in advanced disease.

Authors:  Dylan Harris
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

Review 3.  A systematic review of measures of end-of-life care and its outcomes.

Authors:  Richard A Mularski; Sydney M Dy; Lisa R Shugarman; Anne M Wilkinson; Joanne Lynn; Paul G Shekelle; Sally C Morton; Virginia C Sun; Ronda G Hughes; Lara K Hilton; Margaret Maglione; Shannon L Rhodes; Cony Rolon; Karl A Lorenz
Journal:  Health Serv Res       Date:  2007-10       Impact factor: 3.402

4.  Research priorities in geriatric palliative care: nonpain symptoms.

Authors:  Sara Combs; Benzi M Kluger; Jean S Kutner
Journal:  J Palliat Med       Date:  2013-07-26       Impact factor: 2.947

Review 5.  Benzodiazepines for agitation in patients with delirium: selecting the right patient, right time, and right indication.

Authors:  David Hui
Journal:  Curr Opin Support Palliat Care       Date:  2018-12       Impact factor: 2.302

6.  Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in Patients with Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase-R).

Authors:  Toru Okuyama; Kazuhiro Yoshiuchi; Asao Ogawa; Satoru Iwase; Naosuke Yokomichi; Akihiro Sakashita; Keita Tagami; Keiichi Uemura; Rika Nakahara; Tatsuo Akechi
Journal:  Oncologist       Date:  2019-01-04

7.  Evaluation of the memorial delirium assessment scale (MDAS) for the screening of delirium by means of simulated cases by palliative care health professionals.

Authors:  Nada Fadul; Guddi Kaur; Tao Zhang; J Lynn Palmer; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2007-03-27       Impact factor: 3.603

Review 8.  Neuroleptics in the management of delirium in patients with advanced cancer.

Authors:  David Hui; Rony Dev; Eduardo Bruera
Journal:  Curr Opin Support Palliat Care       Date:  2016-12       Impact factor: 2.302

Review 9.  Improving patient-provider communication: a call to action.

Authors:  Lance Patak; Amy Wilson-Stronks; John Costello; Ruth M Kleinpell; Elizabeth A Henneman; Colleen Person; Mary Beth Happ
Journal:  J Nurs Adm       Date:  2009-09       Impact factor: 1.737

10.  The Bereaved Families' Preferences for Individualized Goals of Care for Terminal Dyspnea: What Is an Acceptable Balance between Dyspnea Intensity and Communication Capacity?

Authors:  Masanori Mori; Tatsuya Morita; Kengo Imai; Naosuke Yokomichi; Takashi Yamaguchi; Kento Masukawa; Yoshiyuki Kizawa; Satoru Tsuneto; Yasuo Shima; Mitsunori Miyashita
Journal:  Palliat Med Rep       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.